MicroRNAs are key regulators of many biological processes, including cell differentiation. Here we show that during human monocyte-macrophage differentiation, expression of the microRNAs miR-223, miR-15a and miR-16 decreased considerably, which led to higher expression of the serine-threonine kinase IKKa in macrophages. In macrophages, higher IKKa expression in conjunction with stabilization of the kinase NIK induced larger amounts of p52. Because of low expression of the transcription factor RelB in untreated macrophages, high p52 expression repressed basal transcription of both canonical and noncanonical NF-kB target genes. However, proinflammatory stimuli in macrophages resulted in greater induction of noncanonical NF-kB target genes. Thus, a decrease in certain microRNAs probably prevents macrophage hyperactivation yet primes the macrophage for certain responses to proinflammatory stimuli.
A r t i c l e s NF-κB proteins are related transcription factors that bind to κB sites in the genome and regulate proinflammatory and immune responserelated genes 1, 2 . They are therefore essential in the development, differentiation and regulation of cells of the immune system. Two mammalian NF-κB proteins, p105 and p100, have long C-terminal domains that inhibit their activity until they are activated by proteasome-mediated cleavage 1, 2 . NF-κB transcription factors bind to DNA as homo-or heterodimers, although activation of transcription is usually achieved only when dimers contain one of the Rel proteins p65 (also called RelA), c-Rel and RelB, which have a C-terminal transactivation domain 1, 2 .
In canonical NF-κB signaling, p105 is constitutively processed by the proteosome into active p50 but is maintained cytoplasmically as a heterodimer (mainly with p65 or c-Rel) by its interaction with inhibitory IκB proteins, such as IκBα, which have a strong nuclear export signal [1] [2] [3] [4] . IκB proteins are phosphorylated by an IKK complex that includes the subunits IKKα and IKKβ and the regulatory subunit IKKγ. Phosphorylation of IκB proteins targets them for ubiquitination and degradation by the proteosome, which allows the p50 heterodimer to move into the nucleus and activate transcription [1] [2] [3] [4] .
Conversely, in the noncanonical NF-κB signaling pathway, p100 is processed to active p52 only when the pathway is activated. Activation involves stabilization of the kinase NIK and its subsequent phosphorylation of IKKα [5] [6] [7] . NIK is usually constitutively and rapidly degraded through complexation with TNF receptor-associated factor (TRAF) adaptors. TRAF3 mediates recruitment of NIK to TRAF2, which recruits the E3 ligases cIAP1 and cIAP2; NIK ubiquitination by these cIAPs then promotes its proteosomal degradation 8, 9 . Stabilized NIK phosphorylates IKKα homodimers, which in turn phosphorylate p100 on its C terminus, resulting in p100 ubiquitination and partial proteolytic processing by the proteosome to p52 (refs. [5] [6] [7] . The active p52 then activates transcription when associated with its binding partner (mainly RelB) [1] [2] [3] [4] .
Canonical and noncanonical NF-κB pathways activate a mostly overlapping yet distinct set of genes 3, 4 . Activation of the canonical pathway is associated with inflammation and innate immune system function through the stimulation of proinflammatory cytokine receptors, such as the tumor necrosis factor (TNF) receptor, Toll-like receptor (TLR) and interleukin receptor families 3, 4 . The noncanonical pathway is associated with adaptive immunity, development of secondary lymphoid organs, B cell maturation and survival, and bone development, and is activated by receptors such as LTβR, BAFF-R, CD40 and RANK 3, 4 .
MicroRNA (miRNA) has emerged as an important component in the differentiation and function of cells involved in the immune response [10] [11] [12] . As RNA molecules ~22 nucleotides in length that are processed from larger transcripts by Drosha and Dicer nucleases, miRNAs are incorporated along with core argonaute proteins into the RNA-induced silencing complex 13 . Binding of this complex to mRNA in mammalian cells can directly or indirectly block translation of the target mRNA or increase its degradation, thus resulting in lower protein expression 11, 13 . The complex of the RNA-induced silencing complex and miRNA binds mainly to 3′ untranslated region (UTR) of mRNA, as recognized by partial sequence complementarity to the 5′ miRNA 'seed' region, which allows the recognition of multiple target mRNAs by a single miRNA and also allows a single protein to be regulated by many miRNAs 14 . Such A r t i c l e s a system is particularly suitable for controlling cell differentiation, in which the development of new cellular properties involves changes in large protein sets and in which multiple components of an important pathway or pathways can be efficiently modulated by the expression of a single miRNA or a set of miRNAs.
Macrophages are chief participants in host inflammatory responses of the innate immune system, and dysregulation of macrophage function is involved in many pathological conditions, including autoimmune disease and cancer 15, 16 . Several miRNAs, including miR-223, miR-155, miR-146, and miR-125b, have a role in the innate immune system [10] [11] [12] 17 . Although the tumor suppressors miR-15a and miR- 16 have not previously been associated with the innate immune system, they are often deleted or downregulated in B cell chronic lymphocytic leukemia, which suggests that they are involved in other immune processes 12 . Of those two miRNAs, miR-15a has been shown to inhibit myeloid colony formation from CD34 + bone marrow cells in vitro 18 .
In this study we found that IKKα mRNA was a target of miR-15a, miR-16 and miR-223. During monocyte-macrophage differentiation, a substantial decrease in these miRNAs allowed a considerable increase in IKKα protein, which then contributed to p52 production. This pathway probably prevents a new macrophage from becoming overactivated by initially acting to repress the activation of NF-κB target genes but prepares it for future NF-κB signaling events that occur during the activation process.
RESULTS

IKKa upregulation during monocyte differentiation
When treating human myeloid leukemia U937 cells with the phorbol ester PMA to induce differentiation, we observed a substantial increase in IKKα (Fig. 1a) . To determine whether such changes occurred in primary human cells, we obtained purified elutriated human monocytes ( Supplementary Fig. 1 , top) and treated them with granulocyte-macrophage colony-stimulating factor (GM-CSF), which induced macrophage differentiation, as verified by morphology ( Supplementary Fig. 1 , bottom) and flow cytometry ( Supplementary  Fig. 2 ). After differentiation, there was considerably higher IKKα protein expression ( Fig. 1b) . Notably, there was little change in the expression of IKKβ or IKKγ. Consistently, in immunoblot analyses of lysates of undifferentiated and differentiated cells from more than 100 donors, almost all samples showed a similar change in IKKα protein expression ( Supplementary Fig. 3 ). Semiquantitative RT-PCR showed a minimal but detectable change between monocytes and macrophages in IKKα mRNA ( Fig. 1c) . Quantitative real-time PCR substantiated a twofold increase in IKKα mRNA ( Fig. 1d) . However, although it was evident that the changing expression of IKKα mRNA contributed to higher protein expression, it was unclear whether the large change in IKKα protein expression was due solely to a small change in IKKα mRNA expression or whether other mechanisms also contributed. We therefore investigated whether additional mechanisms exist to control IKKα protein expression.
Targeting of IKKa mRNA by miRNA
It has been shown that miRNAs not only target mRNA for degradation but also can inhibit mRNA translation 11, 13 . Using the Memorial Sloan-Kettering Cancer Center miRNA database 19 , we searched for miRNAs present in human monocytes with a predicted target sequence in the 3′ UTR of the gene encoding IKKα. We identified possible target sites for the miRNAs let-7, miR-223, miR-16 and miRNA-142-5p and two target sites for miR15a, one of which overlapped the putative miR-16 site ( Fig. 2a) . The target sites for miR-223 and miR-15a-miR16 were only about 35 nucleotides apart, a condition that may result in A r t i c l e s cooperation between target sites, especially of the same miRNA 20 .
With the exception of the putative let-7 target site, which was central, all miRNA target sites were at the 5′ and 3′ ends of the 3′ UTR of the gene encoding IKKα. A published report has suggested that miRNA target sites at either end of the UTR are more likely to be functional targets than are those in the middle 21 .
Next we looked at which miRNAs were much less abundant in GM-CSF-differentiated macrophages relative to their abundance in monocytes. We found only slightly less miR-142-5p in macrophages, whereas let-7 increased ( Fig. 2b) . However, miR-223 was downregulated by 90%, whereas miR-15a and miR-16 were decreased by about 75-80% during macrophage differentiation ( Fig. 2b,c) . Thus, the decrease in the expression of miR-15a, miR-16 and miR-223 correlated with the increase in IKKα protein expression in macrophages, which suggested that these miRNAs could function as modulators of the expression of IKKα mRNA and protein.
To determine whether that was true, we transfected the monocytes with inhibitors of those miRNAs. A combination of inhibitors of miR-223, miR-15a and miR-16 resulted in much higher IKKα protein expression ( Fig. 2d) . Conversely, transfection of molecular mimics of the three miRNAs in macrophages resulted in less IKKα protein ( Fig. 2e) . The amount of IKKβ protein was not notably affected by inhibitors or mimics ( Fig. 2d,e ). This suggests that these particular miRNAs can regulate IKKα protein expression and that they are probably responsible at least in part for the increase in IKKα protein expression observed during macrophage differentiation.
To determine whether the predicted target sites are targeted by miRNAs, we made cytomegalovirus (CMV) promoter-driven luciferase constructs fused to the 3′ UTR region of IKKα mRNA and made mutations in the regions of homology to the various miRNAs. We aligned the IKKα sequences with their respective homologous miRNAs and mutant IKKα sequences ( Fig. 3a) . Mutation of site A destroyed the homology with miR-15a at its first target site, whereas mutation of site C destroyed its second target site and also removed homology to miR-16. Mutation of site B destroyed homology to miR-223.
We cotransfected those constructs into HeLa human cervical cancer cells with a Rous sarcoma virus promoter-driven β-galactosidase expression plasmid and normalized luciferase activity for transfection efficiency to β-galactosidase activity. We further normalized the luciferase activity obtained after transfection of the miRNA mimics for miR-15a, mir-16 or miR-223 to that obtained with a cotransfected control mimic miRNA with no sequence specificity. Each of these mimics resulted in lower luciferase activity produced by the wild-type 3′ UTR reporter construct than by the respective mutant constructs ( Fig. 3b-d) . Mutation of site A alone did not increase luciferase activity in the presence of the miR-15a mimic (Fig. 3b) . When site C was mutated, luciferase activity increased about 25%. However, when both site A and site C were mutated, luciferase activity nearly doubled ( Fig. 3b) , which suggests that both sites are miR-15a targets, although site C is apparently a more effective target. Mutation of site B increased the amount of luciferase activity in the presence of miR-223 ( Fig. 3c) , whereas mutation of site C increased the luciferase activity in the presence of miR-16 (Fig. 3d) . The greater luciferase activity associated with mutation was restricted to the corresponding homologous site in the presence of the respective miRNA mimic. For example, mutations in site A or site C did not increase the relative luciferase activity in the presence of the miR-223 mimic (data not shown).
We next examined the mutations in various combinations by cotransfecting them with miR-15a, mir-16 and miR-223 mimics together. Whereas site C was the most important target site of the three mimics ( Fig. 3e) , there was some cooperation between sites, especially between site A and the other sites, which indicated that in the presence of all three miRNAs, each site has some role in decreasing protein expression. Luciferase activity was probably limited to a decrease of 50% because of the strong CMV promoter driving the construct. Endogenous IKKα protein expression was lower in HeLa cells in the presence of the three mimics, but IKKβ expression was not ( Fig. 3f ). Together these data suggest that miR-15a, miR-16 and miR-223 can modulate IKKα protein expression outside the context of monocyte-macrophage differentiation and that they do in fact target (b-e) Luciferase reporter assays of HeLa cells 48 h after cotransfection of the wild-type IKKα 3′ UTR or the IKKα 3′ UTR reporter constructs in a (horizontal axes) and miRNA mimics (above graphs) or a control mimic, plus Rous sarcoma virus-driven β-galactosidase, normalized to β-galactosidase activity and presented relative to the average value obtained for the control mimic, with the A r t i c l e s the specific target sequences in IKKα mRNA, as determined by the prediction algorithms. To verify that the miRNA had a consequential effect on IKKα protein during differentiation, we transfected monocytes with the mimic pool or control mimic and cultured them in the presence of GM-CSF. We detected a decrease in the IKKα protein expression 4 d after GM-CSF treatment in the presence of the mimic pool (Supplementary Fig. 4) .
Regulation of mRNA by miRNA can occur through inhibition of protein translation or through diminishing mRNA amounts. Transfection of HeLa cells with the pooled mimics decreased the IKKα mRNA by 60% (Fig. 4a) , which was similar to the decrease in macrophages transfected with the pooled mimics ( Fig. 4b) and similar to the difference between macrophages and monocytes in IKKα mRNA (Fig. 1d) . These results indicate these miRNAs regulate IKKα mRNA stability to some extent. However, as the amount of IKKα protein changed much more appreciably than the amount of its mRNA did, it is likely that these miRNAs also regulate translation of IKKα mRNA.
IKKa-targeting miRNAs affect the noncanonical pathway
As IKKα is essential in noncanonical NF-κB signaling, we examined downstream noncanonical components. Although it was minimal in monocytes, p100 processing was substantially greater in macrophages, which led to a large amount of p52 ( Fig. 5a) . Electrophoretic mobilityshift assays showed that whereas κB sites were bound by various NF-κB complexes in both monocytes and macrophages in the absence of treatment, p52 bound to κB sites only in macrophages and not monocytes, as shown by supershifting ( Fig. 5b) . Therefore, higher IKKα protein expression correlated with DNA binding by p52. To further examine activation of the noncanonical NF-κB pathway, we examined NIK stability, a key requirement in this process. Immunoblot analysis showed that substantial NIK protein was present in macrophages but not in monocytes (Fig. 5c) . Additionally, TRAF2, which negatively regulates NIK protein amounts, was much less abundant in the macrophages than in monocytes (Fig. 5c) . The combination of these data suggests that the noncanonical NF-κB pathway is activated after macrophage differentiation. HeLa cells stably express p100 and NIK, which results in constitutive p52 production. We therefore used these cells to examine the effect of IKKα-targeting miRNAs on the events downstream of stabilized NIK. Transfection of pooled miRNA mimics in HeLa cells decreased not only IKKα protein but also p52 without meaningfully affecting p100 (Supplementary Fig. 5) , which demonstrates that a decrease in these miRNAs and an increase in IKKα protein expression could indeed substantially contribute to an increase in p52 downstream of NIK stabilization. In macrophages, pooled mimics diminished not only IKKα protein expression relative to the control mimic but also NIK protein (Fig. 5d) . However, the target site-prediction algorithm did not predict any target sites in NIK mRNA, and when we further examined TRAF2 protein expression in these blots, we found more TRAF2 protein in the presence of these mimics than in control mimic-transfected cells (Fig. 5d) , which suggests that an additional target mRNA of these mimics contributes to activation of the noncanonical pathway upstream of TRAF2 degradation. We obtained similar results with HeLa cells transfected with the mimic pool ( Supplementary Fig. 6 ).
IKKa enables p52-mediated gene repression and activation
To determine the contribution of IKKα to p52 generation, we transfected macrophages with IKKα-specific small interfering RNA (siRNA), as siRNA is more exact in targeting specific mRNA than are miRNA mimics. The IKKα-specific siRNA decreased IKKα protein in macrophages to the amount in monocytes. The amount of p52 was much lower in cells in which IKKα was knocked down than in control cells, but NIK and TRAF2 protein amounts remained similar to those in control cells (Fig. 6a) . We found a similar decrease in the amount of p52 in HeLa cells transfected with IKKα-specific siRNA (Fig. 6b) ; however, these knockdown experiments failed to completely eliminate detectable p52 protein. In macrophages transfected with NIK-specific siRNA, p52 was also decreased but not completely eliminated ( Fig. 6c) , which suggests that both IKKα upregulation and NIK stabilization contribute to p52 generation.
To examine the consequences of a decrease in miRNA expression on gene-transcription events, we examined the expression of known target genes of the noncanonical NF-κB pathway. Although many target genes are shared between the canonical and noncanonical pathways, some genes are believed to be more specific to regulation by the noncanonical pathway. These include the genes encoding A r t i c l e s BLC, ELC, SLC and SDF-1, whose expression is considerably lower in RelB-deficient and NF-κB-deficient mice, as well as in cells from IKKα-deficient mice and mutant knock-in mice expressing IKKα that cannot be activated 22, 23 . As most of these targets encode organogenic chemokines known to be expressed mostly in spleen, we tested whether they were present in human GM-CSF-differentiated macrophages. We did not detect mRNA for BLC, SDF-1 or SLC in these cells. There was, however, quantifiable expression of ELC in most macrophage samples. Unexpectedly, basal ELC mRNA was lower in macrophages than in matched monocyte samples (Fig. 7a) . As p52 was bound to nuclear DNA in macrophages but not in monocytes (Fig. 5b) , we had expected more ELC in macrophages, given that the gene encoding ELC is a known target of the noncanonical pathway. However, these data indicated that p52 might be acting as a repressor of transcription. Consistent with that hypothesis, transfection of GM-CSFdifferentiated macrophages with mimics of miR-15a, miR-16 and miR-223, which decreased IKKα protein expression, increased basal ELC mRNA in macrophages relative to that in cells transfected with the control mimic (Supplementary Fig. 7) .
To test whether further stimulation of the noncanonical pathway led to ELC expression or to further gene repression, we treated these cells with LTα 1 β 2 , the ligand for the lymphotoxin receptor, which strongly activates the noncanonical NF-κB pathway but also activates the canonical NF-κB pathway 22 , and soluble TNF, which activates only the canonical NF-κB pathway 24 . Consistent with published data 22, 23 , activation of the noncanonical pathway by LTα 1 β 2 led to higher ELC mRNA expression ( Supplementary Fig. 8) . Unexpectedly, treatment with TNF also enhanced ELC mRNA expression, albeit to a much lower extent, which suggested that the canonical pathway was also able to mediate expression of the gene encoding ELC in these cells. As we had detected constitutive DNA binding by p65 but not by p52 in monocytes (data not shown and Fig. 5b) , we inferred that the higher basal ELC mRNA expression in monocytes was provided via canonical NF-κB molecules. Correspondingly, transfection of macrophages with the pooled miRNA mimics relieved repression of basal transcription of known canonical NF-κB target genes, including those encoding ICAM, CCL4 and IL-10, but not the gene encoding A20 ( Supplementary  Fig. 9 ), which suggested that p52 also repressed basal transcription from the promoters of some but not all of those genes.
As p52 lacks a transactivation domain, we hypothesized that p52 homodimers, and not the typical transcriptionally active p52-RelB heterodimers, were inhibiting basal gene expression. Indeed, we did not detect any substantial RelB protein in monocytes or in unstimulated macrophages by immunoblot analysis (Fig. 7b) . In agreement with published data showing that RelB is a canonical NF-κB target 25 , lipopolysaccharide (LPS) induced RelB protein expression in macrophages over 24 h of treatment ( Fig. 7b ) and led to a large increase in ELC mRNA over this same time course (Fig. 7c) , consistent with a conversion of repressive p52 homodimers to transcriptionally active p52-RelB heterodimers after stimulation. To verify that p52 was in inhibitory complexes but not in stimulatory complexes, we did crosslinking experiments with macrophages and compared the mobility of various complexes. To decrease the background of unprocessed p100, we immunodepleted most of this protein with an antibody to p100 that recognizes an epitope not present in p52. Immunoblot analysis of the crosslinked proteins showed that RelA and c-Rel were in present in complexes of higher molecular weight in these cells than was p52, whereas we did not detect RelB (Supplementary Fig. 10) , which suggested that p52 was in inhibitory molecular complexes with itself or with p50.
LPS stimulation of GM-CSF-differentiated macrophages led to less induction of the gene encoding ELC in macrophages transfected with the mimic pool than in those transfected with the control mimic ( Fig. 7d,e ), which suggests that p52 activates noncanonical gene transcription in stimulated cells that have substantial RelB expression. However, expression of canonical gene targets was not inhibited by transfection of the miRNA pool, and many were potentiated ( Fig. 7f and Supplementary Fig. 11) , which emphasized the differences in effects of IKKα on noncanonical and canonical signaling A r t i c l e s pathways 26, 27 . To determine whether the effect on basal gene expression and induction by the pooled mimics was due to their effect on IKKα and p52, we used siRNA to knock down these proteins in macrophages. Basal expression of ELC mRNA was higher in these cells than in the control cells ( Supplementary Fig. 12a,b ; effectiveness of p52 knockdown, Supplementary Fig. 12c ), which confirmed that the noncanonical pathway inhibits basal expression of the gene encoding ELC. However, in contrast to expression of A20 mRNA, which was induced, LPS-induced expression of ELC mRNA was largely inhibited when IKKα was knocked down (Supplementary Fig. 12d,e) . Therefore, although higher IKKα protein expression led to repression of basal gene expression of NF-κB target genes, the higher IKKα protein expression enabled activation of noncanonical gene expression after further stimulation of the macrophage by LPS.
DISCUSSION
Macrophages are chief participants in the mediation of host inflammatory responses. Dysregulation of macrophage function can lead to pathological conditions, including autoimmune disease and cancer 15, 16 . However, the molecular events that occur during the differentiation of monocytes into macrophages are still largely unexplored. Although mouse models are useful for in vivo studies, there are now many examples of substantial and distinct differences between mouse monocytes and macrophages and their human counterparts 28 . To learn more about the human system, we chose to study the differentiation process in human cells, which necessitated in vitro studies.
In vitro differentiation of human monocytes into macrophages with GM-CSF was accompanied by a decrease in the expression of miR-15a, miR-16 and miR-223, which led to a substantial increase in IKKα protein expression. The use of M-CSF instead of GM-CSF gave similar results (data not shown), which suggests these changes apply to the differentiation of unstimulated macrophages in general. Target sites for miR-15a, miR-16 and miR-223 in the 3′ UTR of the gene encoding IKKα each contributed to the regulation of IKKα protein expression but did not affect the expression of IKKβ or IKKγ in monocytes or macrophages, which suggests that miR-15a, miR-16 and miR-223 specifically serve to downregulate the noncanonical NF-κB pathway but not the canonical NF-κB pathway. These miRNAs probably regulate noncanonical signaling in other cell types, as miRNA mimics also caused lower constitutive p52 expression in HeLa cells. Regulation of IKKα may contribute to the ability of miR-15a and miR-16 to act as a tumor suppressors in various cell types 29 , as IKKα seems to be involved in prostate cancer 30 and miR-15a and miR-16 act as tumor suppressors in prostate cells 31 .
Downregulation of miR-223, miR-15a and miR-16 during macrophage differentiation probably affects mRNA targets other than IKKα. Both miR-15a and miR-16 negatively regulate the mRNA for the antiapoptotic Bcl-2 molecule 12, 32 . Because Bcl-2 expression increases during differentiation induced by GM-CSF-and M-CSF 33, 34 , our data showing a decrease in these miRNAs during differentiation suggest that they contribute to the known increase in Bcl-2 expression, consistent with their role in regulating this protein 12, 32 . Although we confirmed the importance of changes in IKKα expression after using more specific siRNA to IKKα, we also observed lower NIK protein expression in response to miRNA mimics. However, we found no predicted target sites in NIK, and the increase in TRAF2 expression suggests an indirect effect of the mimics on NIK, perhaps via targets that regulate TRAF2 degradation.
High expression of miR-223 has been demonstrated in granulocytes, especially peripheral blood neutrophils 17 , which have the same myeloid progenitor lineage as monocytes. Mice lacking miR-223 have profound neutrophilia in peripheral blood and extensive granulocyte hyperplasia in the bone marrow due to hyperproliferation of granulocyte-monocyte progenitor cells 17 . Granulocytes lacking miR-223 are hypersensitive to activating stimuli 17 . As NF-κB activity regulates the production of cytokines and chemokines in neutrophils in response to proinflammatory stimuli 35 , and NF-κB components are also necessary for regulation of granulocytic progenitors 36 , it is not unreasonable to speculate, on the basis of our data, that some of the phenotype of miR-223-deficient mice could be the result of increased noncanonical NF-κB activity and decreased canonical NF-κB activity due to higher IKKα expression.
IKKα is a negative regulator of inflammation in mouse models of innate immune responses 26, 27 . Macrophages from knock-in mice with inactive IKKα are hyperactive, which leads to more bactericidal activity in vivo and in vitro and greater susceptibility of these mice to septic shock 26 . Likewise, cells from IKKα-deficient mice show enhanced phagocytotic clearance of bacteria and higher expression of canonical NF-κB target genes, including those encoding proinflammatory cytokines and chemokines 27 . Those studies are consistent with our data showing that an miRNA-mediated decrease in IKKα led to higher expression of canonical NF-κB targets in stimulated and unstimulated cells. IKKα is proposed to contribute to the suppression of canonical NF-κB activity by accelerating the turnover and DNA binding of RelA and c-Rel 26 or by preventing the hyperactivation of IKKβ by proinflammatory stimuli 26, 27 . Our data do not exclude those possibilities; however, we found that increased IKKα expression during macrophage differentiation was accompanied by the generation of p52 and its binding to DNA, which led not to gene activation but to gene repression, perhaps as a p52 homodimer. Although there are cases in which p52 and p50 homodimers, which lack transactivation domains, can activate gene expression in association with proteins such as Bcl-3 and IκBζ, normally p50 and p52 homodimers repress gene transcription 1, 2, 37, 38 .
The binding of NF-κB dimers is complex but highly adaptable to cellular situations. NF-κB dimers are associated with promoters only transiently (on the order of seconds), and therefore promoter-bound dimers are in dynamic equilibrium with nucleoplasmic dimers 39 . Consequently, the nature of cellular NF-κB dimers is particularly sensitive to the concentration of a given NF-κB component. In our study, activation of the noncanonical NF-κB target gene encoding ELC required activation of the macrophages by additional stimuli and correlated with the production of RelB, which was undetectable in monocytes and had only very low expression in unstimulated macrophages. These data are consistent with a study showing that production of RelB is a chief contributing factor to the activation of noncanonical NF-κB dimers 40 .
Thus, it seems likely that an increase in IKKα during the differentiation process serves two purposes: first, it acts as a brake that prevents hyperactivation of the new macrophage, perhaps in part by repressing basal gene transcription through upregulation of p52 in the absence of RelB expression; and second, it provides additional activation of noncanonical gene transcription when the cell receives further stimuli, transforming the excess p52 from a repressor of gene transcription to an activator of gene transcription in the presence of synthesis of new RelB protein. The new macrophage is therefore not spontaneously activated and becomes fully committed to an inflammatory response with its full range of cytokine and chemokine gene expression only when there is substantial stimulation. Our results indicate that a decrease in certain miRNAs during differentiation leads to conditions in which macrophages can adequately respond to infection but additional tissue damage or autoimmune conditions are prevented.
A r t i c l e s METHODS Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
